Cardiac Pacing Control for VT/VF Detection Before Pulse Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing medical devices struggle to accurately distinguish between ventricular tachyarrhythmia (VT) and ventricular fibrillation (VF) during cardiac pacing, often delivering pacing pulses during undetected or undersensed VT/VF episodes, which can interfere with proper rhythm detection and delay necessary tachyarrhythmia therapy.
Innovation Solution
A medical device analyzes cardiac electrical signals before delivering pacing pulses, delaying or canceling them if evidence of VT/VF is detected, using morphology metrics and frequency content analysis to verify the absence of VT/VF rhythms, thereby preventing pacing during undetected arrhythmias.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the medical device delivers pacing pulses based on standard escape intervals, then bradycardia treatment is provided, but pacing pulses may be delivered during undetected VT/VF episodes
Solution Approach 1:
The system performs preliminary analysis of cardiac signal morphology and frequency content during the pacing escape interval before the pacing pulse is delivered. This advance detection of VT/VF characteristics prevents inappropriate pacing delivery while maintaining the standard pacing escape interval timing.
Solution Approach 2:
The patent replaces simple timing-based pacing control with signal processing-based detection using morphology metrics and frequency analysis. This substitution enables more accurate discrimination between normal and arrhythmic rhythms without requiring complex additional hardware.
2Measurement precision
If the medical device performs detailed signal analysis before pacing, then accuracy of detecting VT/VF improves, but the timing of pacing pulse delivery is delayed
Solution Approach 1:
The signal analysis is performed during the existing pacing escape interval before the pacing pulse would naturally be delivered. This preliminary detection of VT/VF characteristics eliminates additional time delays while maintaining precise detection through morphology and frequency analysis.
Solution Approach 2:
The system continuously monitors cardiac signals during the pacing escape interval, performing morphology and frequency analysis without interrupting the normal pacing timing sequence. This continuous monitoring ensures timely detection and prevents pacing delays.
3Device complexity
If the medical device uses extracardiac leads for sensing, then device complexity is reduced, but signal strength and quality decrease
Solution Approach 1:
The system changes the analysis parameters by focusing on morphology metrics and frequency content rather than relying solely on signal amplitude. This parameter transformation enables accurate VT/VF detection using the lower-amplitude signals from extracardiac leads.
Solution Approach 2:
The patent substitutes simple amplitude-based detection with sophisticated signal processing techniques including morphology analysis and frequency domain analysis. This substitution compensates for the lower signal strength from extracardiac leads and maintains detection precision.
Data Source
AI summary
A medical device is configured to determine tachyarrhythmia evidence in a cardiac signal segment received from a cardiac electrical signal sensed during a pacing escape interval started to schedule a pending cardiac pacing pulse. The medical device may delay the pending cardiac pacing pulse in response to determining the tachyarrhythmia evidence during the pacing escape interval.